Journal of Woundcare Handbook

The professional's guide to wound product selection

UrgoStart Plus Pad

UrgoStart Plus Pad

Urgo Medical


polyabsorbent fibre pad containing a protease inhibitor (TLC-NOSF Healing Matrix) and polyabsorbent fibres. The TLC-NOSF Healing Matrix inhibits excess metalloproteinases and promotes angiogenesis. The polyabsorbent fibres bind, trap and retain exudate, slough and debris. NICE 2019 medical technology guidance (MTG42) states that evidence supports the case for adopting UrgoStart dressings to treat diabetic foot ulcers and venous leg ulcers.



For all stages (from desloughing to complete healing) of exuding wounds including leg ulcers, diabetic foot ulcers, pressure ulcers, and long-standing acute wounds.


Do not use on heavily bleeding wounds, cancerous wounds, wounds that may reveal a deep abscess, infected wounds or where there is a known sensitivity to the dressing.

Sizes Available

Pad: 6x6cm; 10x10cm; 15x20cm


Pad: £3.46; £5.07; £11.36

More on: Other dressings , Desloughing dressing , Protease modulating dressings